Shearman Mark S

Number of records: 9
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
15-Feb-23 4:30 PM
View: 
Editas Medicine, Inc. (EDIT) 13-Feb-23Sale 2,790$9.67$26,966.20(4%)
68.35K to 65.56K
16-Jun-22 4:15 PM
View: 
Editas Medicine, Inc. (EDIT) 15-Jun-22Sale 5,145$10.06$51,744.80(7%)
73.49K to 68.35K
11-Feb-22 4:21 PM
View: 
Editas Medicine, Inc. (EDIT) 10-Feb-22Grant 31,709----76%
41.78K to 73.49K
23-Dec-21 4:10 PM
View: 
Editas Medicine, Inc. (EDIT) 22-Dec-21Grant 9,084----28%
32.7K to 41.78K
16-Jun-21 4:19 PM
View: 
Editas Medicine, Inc. (EDIT) 14-Jun-21Grant 32,701----100%
0 to 32.7K
18-Aug-20 6:15 PM
View: 
Applied Genetic Technologie... (AGTC) 15-Aug-20Payment of Exercise 5,723$5.77$33,021.70(15%)
39.0K to 33.28K
19-Aug-19 7:57 PM
View: 
Applied Genetic Technologie... (AGTC) 15-Aug-19Grant 39,000----100%
0 to 39.0K
18-Dec-18 7:58 PM
View: 
Applied Genetic Technologie... (AGTC) 14-Dec-18Market Sale 3,000$3.35$10,052.70(100%)
3.0K to 0
3%
26-Sep-16 5:20 PM
View: 
Applied Genetic Technologie... (AGTC) 22-Sep-16Market Purchase 3,000$8.87$26,601.50100%
0 to 3.0K
(66%)